• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Bromobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Bromobenzenes

Introduction to 1-Bromo-3-n-octylbenzene (CAS No: 663949-34-6)

1-Bromo-3-n-octylbenzene, with the chemical formula C₁₂H₁₇Br, is a brominated aromatic compound that has garnered significant attention in the field of organic synthesis and pharmaceutical research. This compound serves as a versatile intermediate in the development of various chemical entities, particularly in the synthesis of biologically active molecules. Its unique structural features, combining a bromine substituent with an octyl side chain, make it a valuable building block for further functionalization. The CAS number 663949-34-6 uniquely identifies this compound in scientific literature and industrial applications.

The synthesis of 1-Bromo-3-n-octylbenzene typically involves the bromination of toluene derivatives, where selective substitution at the third position is achieved through controlled reaction conditions. The presence of the octyl group enhances the lipophilicity of the molecule, making it particularly useful in drug delivery systems and membrane interactions. Recent advancements in synthetic methodologies have improved the yield and purity of this compound, facilitating its use in high-throughput screening and medicinal chemistry programs.

In pharmaceutical research, 1-Bromo-3-n-octylbenzene has been explored as a precursor for various therapeutic agents. Its bromine moiety allows for further modifications via cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings, enabling the introduction of diverse functional groups. These reactions are pivotal in constructing complex molecular architectures that mimic natural products or designed pharmacophores. For instance, researchers have utilized this compound to develop novel antifungal agents and kinase inhibitors, leveraging its ability to undergo sequential functionalization.

The octyl group in 1-Bromo-3-n-octylbenzene contributes to its solubility characteristics, making it compatible with both organic and aqueous phases during synthesis and formulation processes. This property is particularly advantageous in developing prodrugs or formulations that require controlled release mechanisms. Additionally, the compound's stability under various reaction conditions has made it a preferred choice for industrial-scale synthesis, ensuring consistent quality and performance.

Recent studies have highlighted the role of 1-Bromo-3-n-octylbenzene in materials science, particularly in the development of liquid crystals and organic semiconductors. The bromine substituent facilitates polymerization reactions, allowing for the creation of conjugated polymers with applications in optoelectronic devices. These materials exhibit desirable properties such as high charge carrier mobility and thermal stability, making them suitable for use in organic light-emitting diodes (OLEDs) and photovoltaic cells.

The pharmaceutical industry has also explored derivatives of 1-Bromo-3-n-octylbenzene for their potential antimicrobial properties. Structural modifications have led to compounds with enhanced activity against resistant strains of bacteria and fungi. The octyl chain's hydrophobic nature aids in membrane penetration, improving bioavailability and therapeutic efficacy. Furthermore, computational modeling has been employed to predict binding affinities and optimize lead compounds derived from this scaffold.

In conclusion, 1-Bromo-3-n-octylbenzene (CAS No: 663949-34-6) is a multifaceted compound with broad applications across organic synthesis, pharmaceuticals, and materials science. Its unique structural features enable diverse functionalization pathways, making it an indispensable tool for researchers seeking to develop novel chemical entities. As synthetic methodologies continue to evolve, the utility of this compound is expected to expand further, driving innovation in multiple scientific domains.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)